CIPLA
Back to Balance Sheet
|
CIPLA Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹-748 Cr | ₹-591 Cr | ₹-403 Cr | ₹-293 Cr | ₹-205 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of CIPLA ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2026 | ₹-748 Cr |
| Mar2025 | ₹-591 Cr |
| Mar2024 | ₹-403 Cr |
| Mar2023 | ₹-293 Cr |
| Mar2022 | ₹-205 Cr |
How is Deferred Tax Assets / Liabilities of CIPLA Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹-748 Cr | Negative | |
| Mar2025 | ₹-591 Cr | Negative | |
| Mar2024 | ₹-403 Cr | Negative | |
| Mar2023 | ₹-293 Cr | Negative | |
| Mar2022 | ₹-205 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of CIPLA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CIPLA | ₹114,398.6 Cr | -0.3% | -3.9% | -11.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹469,310.0 Cr | 2% | -1.7% | 15.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹245,426.0 Cr | 6.5% | 14.8% | 48.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹189,347.0 Cr | 1.2% | -2.5% | 37.2% | Stock Analytics | |
| MANKIND PHARMA | ₹99,077.7 Cr | 1.4% | -2.9% | -6.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,240.2 Cr | -2.2% | 1.5% | -8.3% | Stock Analytics | |
CIPLA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CIPLA | -0.3% |
-3.9% |
-11.4% |
| SENSEX | -0.5% |
-1.3% |
-5.4% |
You may also like the below Video Courses